Author(s): Shackleton M, Quintana E, Fearon ER, Morrison SJ
Abstract Share this page
Abstract The identification and characterization of cancer stem cells might lead to more effective treatments for some cancers by focusing therapy on the most malignant cells. To achieve this goal it will be necessary to determine which cancers follow a cancer stem cell model and which do not, to address technical issues related to tumorigenesis assays, and to test the extent to which cancer cell heterogeneity arises from genetic versus epigenetic differences.
This article was published in Cell
and referenced in Journal of Molecular Biomarkers & Diagnosis